Christopher P. Kiritsy - Dec 2, 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
Director
Signature
/s/ Thomas Bures, Attorney-in-Fact
Stock symbol
PIRS
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/9/2024, 07:32 AM
Previous filing
Jun 23, 2023
Next filing
Dec 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +500 $0.00 500 Dec 2, 2024 Common Stock 500 $16.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to 100% of the underlying shares on December 2, 2025, subject to the Reporting Person's continued service as a director through the vesting date.